ARS Pharmaceuticals, Inc. 8-K SEC Filing July 2026 – Company Info, Stock Symbol SPRY, and Nasdaq Listing
ARS Pharmaceuticals, Inc. 8-K Report: Key Leadership Changes...
Sign in to continue:
ARS Pharmaceuticals, Inc. 8-K Report: Key Leadership Changes...
Grayscale Ethereum Staking Mini ETF: Material U.S. Federal I...
Csquare, Inc. 8-K Filing: IPO, Registration Rights, and Gove...
Grayscale Ethereum Staking ETF: Material U.S. Federal Income...
Clover Health Reports Cybersecurity Incident: Key Details fo...
EyePoint, Inc. Announces DOJ Settlement and Corporate Integr...
Key Highlights Investors Must Know Detalimogene vorapla...
TransCode Therapeutics, Inc. Announces Amendment and Restate...
Polomar Health Services, Inc. Announces Change of Independen...
Deep Fission, Inc. - Investor Update: Significant Amendment ...